Brain Implants Market Size Worth $9.2 Billion By 2028 | CAGR: 9.1%: Contrive Datum Insights, Inc.

The global brain implants

market size is anticipated to reach USD 9.2 billion by

2028, according to a new report by Contrive Datum Insights, Inc. The market is

expected to expand at a CAGR of 9.1% from 2021 to 2028. The rise in

neurological disorders such as epilepsy, Parkinson’s disease, depression, and

tremors as well as growing investments in R&D to develop cost-effective

brain implants is attributing to the growth of the market.

Key suggestions from the


·       On the basis of product type, the deep brain stimulator segment dominated the market in 2020 with a share of 37.0%, owing to the rising geriatric population prone to neurological diseases, coupled with growing investments in the development of the medical device

·       Based on application, the chronic pain segment dominated the market in 2020 with a share of 58.8%, due to the increasing prevalence of chronic pain disorders such as migraine, leg pain, and disk surgery pain. According to Migraine Research Foundation 2020, migraine is the 3rd most prevalent neurological illness across the world, affecting 1 billion people worldwide

·       North America dominated the market with the highest revenue share of 42.9% in 2020. This is due to the high prevalence of psychological disorders, availability of highly skilled physicians, and rise in awareness about treatments in this continent

·       Asia Pacific is expected to significantly lead the market in the future from 2021 to 2028 owing to increasing affordability, and the rising number of awareness programs about brain implants benefits

Read 120 page research report

with ToC on “Brain Implants Market Size, Share & Trends Analysis

Report By Product (Deep Brain Stimulator, Vagus Nerve Stimulator, Spinal Cord

Stimulator), By Application (Chronic Pain, Parkinson’s Disease, Epilepsy), By

Region, And Segment Forecasts, 2021 – 2028” at:

The presence of a large population base suffering from various neurological and physiological disorders and conditions is expected to boost the demand for implants during the forecast period. For instance, as per the Parkinson’s Foundation 2016 report, over 10 million people globally are living with Parkinson’s disease (PD). Thus, the increasing cases of PD are expected to drive the market. However, the outbreak of the COVID-19 pandemic is restricting the growth of the market. For instance, as per the Neuromodulation Society of the U.K. and Ireland, in the U.K. all the NHS hospitals were instructed to suspend all the non-urgent elective surgeries due to the pandemic from 15th April in 2020 for at least three months.

In addition, technological

advancements such as self-charging implants and memory chips are anticipated to

provide the market with growth opportunities over the forecast period. For

instance, in January 2020, Abbott’s Infinity DBS received an extended

indication approval from the U.S. FDA for PD treatment.

Contrive Datum Insights has

segmented the global brain implants market on the basis of product,

application, and region:

·       Brain Implants Product Outlook (Revenue, USD Million, 2016 – 2028)

·       Deep Brain Stimulator

·       Spinal Cord Stimulator

·       Vagus Nerve Stimulator

·       Brain Implants Application Outlook (Revenue, USD Million, 2016 – 2028)

·       Chronic Pain

·       Epilepsy

·       Parkinson’s Disease

·       Depression

·       Essential Tremor

·       Alzheimer’s Disease

·       Brain Implants Regional Outlook (Revenue, USD Million, 2016 – 2028)

·       North America

·       U.S.

·       Canada

·       Europe

·       Germany

·       U.K.

·       France

·       Italy

·       Spain

·       Asia Pacific

·       Japan

·       China

·       India

·       Australia

·       South Korea

·       Latin America

·       Mexico

·       Brazil

·       Argentina

·       Colombia

·       Middle East & Africa

·       South Africa

·       Saudi Arabia

·       UAE

List of Key Players of Brain

Implants Market

·       Medtronic

·       Boston Scientific Corporation

·       St. Jude Medical (Abbott)

·       NeuroPace, Inc.

·       Nevro Corporation

·       Synapse Biomedical Inc.

·       Aleva Neurotherapeutics SA

Get More Info:-


Leave a Reply

Your email address will not be published. Required fields are marked *